Delivery Order SPE2DB22D2103-SPE2DB24FR9GK
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $15,278.40 for the supply of RINVOQ ER 30 MG TABLET under a Firm Fixed Price contract. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on December 6, 2023, with a completion date of December 7, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $27,077.33, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 28, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc....
- This federal contract award, valued at $9,659.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of December 11, 2023. The contract is not designated as a set-aside award, indicating it was competitively awarded. Amerisourcebergen Drug Corp, as a major pharmaceutical...
- This federal contract award, valued at $13,278.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563012002 RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023, and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award, valued at $36,888.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a completion date of February 9, 2024. This contract is a delivery order, with a firm fixed price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products. The award, valued at $17,908.87, is a firm fixed-price delivery order with a completion date of February 13, 2024. The contract covers the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $38,116.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, to support military and federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $22,854.65, is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on January 12, 2024. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,697.38 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 15 MG TABLET. The order has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $35,848.78, is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract is a firm fixed-price delivery order with a performance period through December 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR9GKDelivery Order
This federal contract award, valued at $24,205.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 1, 2024. The contract covers the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds significant Indefinite Delivery Contracts with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support various government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 4/30/24 |